Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option

od Passaro, Antonio, de Marinis, Filippo
Izdano u Transl Lung Cancer Res (2018)

Looking for the high way in EGFR-positive non-small cell lung cancer through the evaluation of survival endpoints

od Passaro, Antonio, de Marinis, Filippo
Izdano u Transl Lung Cancer Res (2019)

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

od Ricciardi, Serena, Tomao, Silverio, de Marinis, Filippo
Izdano 2009

Afatinib as first-line treatment for patients with advanced non-small-cell lung cancer harboring EGFR mutations: focus on LUX-Lung 3 and LUX-Lung 6 phase III trials

od Passaro, Antonio, Gori, Bruno, de Marinis, Filippo
Izdano 2013

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

od Ricciardi, Serena, Tomao, Silverio, de Marinis, Filippo
Izdano u Lung Cancer (Auckl) (2010)

Brain metastases in EGFR-positive non-small cell lung cancer: the way to the sanctuary becomes less winding

od Passaro, Antonio, Gianoncelli, Letizia, Stati, Valeria, de Marinis, Filippo
Izdano u Ann Transl Med (2019)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)

od Normanno, Nicola, Barberis, Massimo, De Marinis, Filippo, Gridelli, Cesare
Izdano u Cancers (Basel) (2020)

Proposals for revisions of the classification of lung cancers with multiple pulmonary sites: the radiologist’s, thoracic surgeon’s and oncologist’s point of view

od Rizzo, Stefania, Petrella, Francesco, Passaro, Antonio, de Marinis, Filippo, Bellomi, Massimo
Izdano u J Thorac Dis (2016)

Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way

od Attili, Ilaria, Passaro, Antonio, Spaggiari, Lorenzo, Spitaleri, Gianluca, de Marinis, Filippo
Izdano u Ann Transl Med (2020)

Cellular and molecular biology of small cell lung cancer: an overview

od Karachaliou, Niki, Pilotto, Sara, Lazzari, Chiara, Bria, Emilio, de Marinis, Filippo, Rosell, Rafael
Izdano u Transl Lung Cancer Res (2016)

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

od Gori, Bruno, Ricciardi, Serena, Fulvi, Alberto, Intagliata, Salvatore, Signore, Ester Del, de Marinis, Filippo
Izdano 2011

Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies

od Davies, Jessica, Patel, Manali, Gridelli, Cesare, de Marinis, Filippo, Waterkamp, Daniel, McCusker, Margaret E.
Izdano u PLoS One (2017)

The Impact of Multidisciplinary Team Meetings on Patient Management in Oncologic Thoracic Surgery: A Single-Center Experience

od Petrella, Francesco, Radice, Davide, Guarize, Juliana, Piperno, Gaia, Rampinelli, Cristiano, de Marinis, Filippo, Spaggiari, Lorenzo
Izdano u Cancers (Basel) (2021)

Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

od Grossi, Francesco, Kubota, Kaoru, Cappuzzo, Federico, de Marinis, Filippo, Gridelli, Cesare, Aita, Marianna, Douillard, Jean-Yves
Izdano 2010

Afatinib in first-line setting for NSCLC harbouring common EGFR mutations: new light after the preliminary results of LUX-Lung 7?

od Passaro, Antonio, Pochesci, Alessia, Spitaleri, Gianluca, Catania, Chiara, Noberasco, Cristina, Del Signore, Ester, de Marinis, Filippo
Izdano u J Thorac Dis (2016)

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

od Passaro, Antonio, Lazzari, Chiara, Karachaliou, Niki, Spitaleri, Gianluca, Pochesci, Alessia, Catania, Chiara, Rosell, Rafael, de Marinis, Filippo
Izdano u Onco Targets Ther (2016)

Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

od Gridelli, Cesare, Ardizzoni, Andrea, Barberis, Massimo, Cappuzzo, Federico, Casaluce, Francesca, Danesi, Romano, Troncone, Giancarlo, De Marinis, Filippo
Izdano u Transl Lung Cancer Res (2017)

Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients

od Fumagalli, Caterina, Catania, Chiara, Ranghiero, Alberto, Bosi, Carlo, Viale, Giuseppe, de Marinis, Filippo, Barberis, Massimo, Guerini-Rocco, Elena
Izdano u J Clin Med (2019)

A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expres...

od Herbst, Roy, Jassem, Jacek, Abogunrin, Seye, James, Daniel, McCool, Rachael, Belleli, Rossella, Giaccone, Giuseppe, De Marinis, Filippo
Izdano u Front Oncol (2021)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

od Miele, Evelina, Spinelli, Gian Paolo, Tomao, Federica, Zullo, Angelo, De Marinis, Filippo, Pasciuti, Giulia, Rossi, Luigi, Zoratto, Federica, Tomao, Silverio
Izdano 2008